Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Grants, U.S. Government Contract and Joint Venture [Abstract]

Schedule of increase (decrease) in accounts receivable, unbilled services, and deferred revenue

During the nine months ended September 30, 2022, changes in the Company's accounts receivables and deferred revenue balances were as follows (in thousands):

	December 31, 2021		Additions	Deductions	September 30, 2022
Contract receivables:
Accounts receivable	$	454,993	1,519,345	(1,862,693)	$	111,645
Contract liabilities:
Deferred revenue(1)	$	1,595,472	96,298	(251,576)(2)	$	1,440,194

(1)    Amount is comprised of $404.8 million and $1.4 billion of current Deferred revenue and $1.0 billion and $172.5 million of non-current Deferred revenue as of September 30, 2022 and December 31, 2021, respectively.

(2)    Deductions from Deferred revenue includes $202.5 million that was realized in Revenue and $49.1 million that was reclassified to Other liabilities.

Schedule of revenue by major customers by reporting segments

The Company recognized grant revenue as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
U.S. government partnership (“OWS”)	$	104,348	$	96,215	$	311,423	$	699,268
U.S. Department of Defense (“DoD”)	1,925		1,287		1,925		21,472
Coalition for Epidemic Preparedness Innovations (“CEPI”)	—		37,505		—		131,022
Bill & Melinda Gates Foundation (“BMGF”)	—		—		—		2,628
Total grant revenue	$	106,273	$	135,007	$	313,348	$	854,390